English

HC Andersen Capital Events 31/08: Explore the latest in the Nordic Life Science industry

Report this content

Life Science Seminar 2023
Do you want to know more about the latest development in the Nordic Life Science industry? Get an update on HC Andersen Capital's view on valuation as well as presentations from listed Life Science companies focussing on their late-stage pipeline. 

We have the pleasure of welcoming Bavarian Nordic, Gubra, ExpreS2ion Biotechnologies, Ascelia Pharma, Pharma Equity Group, Curasight, Hansa Biopharma, Qlife, Index Pharmaceuticals, NeoDynamics and BioPorto.

You can find the agenda for the seminar here.

Disclaimer: HC Andersen Capital receives payment from Bavarian Nordic, Gubra, ExpreS2ion Biotechnologies, Ascelia Pharma, Pharma Equity Group, Curasight, BioPorto, Hansa Biopharma, Qlife, Index and NeoDynamics for a Digital IR/corporate visibility agreement. // Olivier A. de Goeij 08:45, 31-08-2023.

Thursday 31 August at 08.45 - 14:25

Sign up via link.

Subscribe